Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study

BACKGROUND: The CHAARTED and LATITUDE trials demonstrated a prolonged overall survival (OS) for metastatic hormone-naïve prostate cancer (mHNPC) patients who receive up-front docetaxel or abiraterone acetate. These studies used their own risk criteria: CHAARTED trial defines high- and low-volume dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomed Res Int
Hauptverfasser: Kawahara, Takashi, Yoneyama, Shuko, Ohno, Yoshio, Iizuka, Junpei, Hashimoto, Yasunobu, Tsumura, Hideyasu, Tabata, Ken-ichi, Nakagami, Yoshihiro, Tanabe, Kazunari, Iwamura, Masatsugu, Uemura, Hiroji, Miyoshi, Yasuhide
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352129/
https://ncbi.nlm.nih.gov/pubmed/32714984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7804932
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge